EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
6.4.1.5 | Alzheimer Disease |
26629917 |
Lysosomal Enzyme Glucocerebrosidase Protects against A?1-42 Oligomer-Induced Neurotoxicity. |
causal interaction unassigned |
3 0 |
6.4.1.5 | Anosmia |
27648471 |
GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis. |
causal interaction diagnostic usage therapeutic application unassigned |
2 1 1 0 |
6.4.1.5 | Brain Diseases |
33551744 |
Ambroxol Upregulates Glucocerebrosidase Expression to Promote Neural Stem Cells Differentiation Into Neurons Through Wnt/?-Catenin Pathway After Ischemic Stroke. |
causal interaction unassigned |
3 0 |
6.4.1.5 | Dementia |
25881142 |
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies. |
causal interaction therapeutic application unassigned |
3 2 0 |
6.4.1.5 | Dementia |
26149921 |
Increased oligomerization and phosphorylation of ?-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains. |
unassigned |
0 |
6.4.1.5 | Dementia |
28835999 |
Glucocerebrosidase expression patterns in the non-human primate brain. |
causal interaction therapeutic application unassigned |
3 1 0 |
6.4.1.5 | Dementia |
31351996 |
The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease. |
causal interaction therapeutic application unassigned |
3 4 0 |
6.4.1.5 | Dementia |
32470554 |
Increased ?-synuclein oligomerization is associated with decreased activity of glucocerebrosidase in the aging human striatum and hippocampus. |
unassigned |
0 |
6.4.1.5 | Dementia |
34151863 |
Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations. |
causal interaction unassigned |
4 0 |
6.4.1.5 | Dementia |
34175090 |
Mini review - The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease. |
causal interaction therapeutic application unassigned |
4 4 0 |